-
mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021
-
View Affiliations Hide AffiliationsBaltazar Nunesbaltazar.nunes insa.min-saude.pt
-
View Citation Hide Citation
Citation style for this article: . mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021. Euro Surveill. 2021;26(38):pii=2100833. https://doi.org/10.2807/1560-7917.ES.2021.26.38.2100833 Received: 27 Aug 2021; Accepted: 22 Sept 2021
- Previous Article
- Table of Contents
- Next Article
Abstract
Through deterministic data linkage of health registries, mRNA vaccine effectiveness (VE) against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older adults. VE against hospitalisations was 94% (95% confidence interval (CI): 88–97) and 82% (95% CI: 72–89) for those 65–79 and ≥ 80 years old, with no evidence of waning 98 days after dose two. VE against mortality was 96% (95% CI: 92–98) and 81% (95% CI: 74–87) in these two age groups.
Full text loading...